NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE

This adverse event was reported 9 times

These drugs are most commonly taken by patients reporting NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE:

# Drug Count
0 METHOTREXATE 6
1 METHOTREXATE SODIUM 6
2 CLOZAPINE 5
3 CYCLOPHOSPHAMIDE 5
4 CYCLOPHOSPHAMIDE FOR INJECTION 5
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 5
6 CYTARABINE 5
7 ETOPOSIDE 5
8 IFOSFAMIDE 5
9 IFOSFAMIDE FOR INJECTION 5
See all common drugs associated with NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE

NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MESNA INJECTION 5 0.0006
1 MESNA 5 0.0006
2 IFOSFAMIDE FOR INJECTION 5 0.0002
3 MITOXANTRONE HYDROCHLORIDE 1 0.0002
4 ANTI-THYMOCYTE GLOBULIN (RABBIT) 1 0.0001
5 CYTARABINE 5 0.0001
6 ETOPOSIDE 5 0.0001
7 VINCRISTINE SULFATE 2 0.0001
8 CLOZAPINE 5 0.0000
9 IMATINIB MESYLATE 1 0.0000
See all drugs enriched for association with NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE

NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 5 0.0001
1 Alkylating Drug [EPC] 5 0.0000
2 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
3 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
5 Atypical Antipsychotic [EPC] 5 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 Vitamin C [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE